Tayyaba Hasan of Harvard University in the U.S. will work to design a conjugate which will attach to the GP63 enzyme of the Leishmania parasite. This therapy will consist of a lightactivatable, non-toxic chemical that will be activated by a light source, killing the parasite but leaving surrounding cells intact.
Grant ID
OPP51831
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False